Clearbridge BioLoc’s beginnings originated from its patent pending AssayQuest™ platform.
An innovative, yet affordable platform that was designed to be a complete point-of-care-testing
(POCT) platform that facilitates quantitative POCT from small amounts of patient sample. Furthermore,
the platform is empowered with standard telecommunication protocol to deliver telehealthcare efficiently.
The ClearQuest™ platform was born out of a need for diagnostic use in low-resource settings. Clearbridge BioLoc reengineered the ImmunoCard to become a stand-alone test kit platform, delivering diagnostic point-of-care-testing without the need of an ImmunoAnalyzer or power.